ImmunoPrecise Antibodies Stock (NASDAQ: IPA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 588.034K |
Day Range | - - - |
52 Wk Range | 0.940 - 4.220 |
Market Cap | $32.631M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 1.38% |
Days to Cover | 1.35 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ImmunoPrecise Antibodies (NASDAQ: IPA) through any online brokerage.
There are no as such competitors for ImmunoPrecise Antibodies.
The latest price target for ImmunoPrecise Antibodies (NASDAQ: IPA) was reported by Benchmark on Friday, March 15, 2024. The analyst firm set a price target for 5.00 expecting IPA to rise to within 12 months (a possible 303.23% upside). 5 analyst firms have reported ratings in the last year.
The stock price for ImmunoPrecise Antibodies (NASDAQ: IPA) is $1.24 last updated April 15, 2024 at 7:15 PM EDT.
There are no upcoming dividends for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies’s Q4 earnings are confirmed for Friday, July 5, 2024.
There is no upcoming split for ImmunoPrecise Antibodies.
ImmunoPrecise Antibodies is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.